SHR banner small

HOME SHR HEART STUDIES SHR THYROID STUDIES SHR CANCER STUDIES SHR-FUNDED AKC/CHF STUDIES SHR INC DONATIONS CONFERENCE REPORTS HEALTH ARTICLES

How do
I donate samples
for Saluki studies?

 

Your tax-deductible donations, made payable to SHR Inc, should be sent to

MaryDee Sist DVM
1629 Meech Road
Williamston, MI 48895

517-655-1354
517-655-5551
Salukihealth@aol.com

SHR-SUPPORTED
AKC CHF STUDIES

click on Grant Number to view entire article

As of 11/2015 Saluki Health Research, Inc. has contributed $52,233.00 in support of the following AKC/Canine Health Foundation Grants. Grant Progress reports received at various times have been published in ASA and SCOA Newsletters. The latest Grant Progress reports are linked to the Grant number.

Grant 01771: Defining the Unique Genetic Markers in Dogs That Define Immune Function, Disease Resistance and Tissue Transplantation, 30 December, 2016

Grant 02242: Understanding the Genetics of Adverse Drug Reactions in Sighthounds, 1 February, 2016

Grant No. 02217: A Novel Mechanism to Regulate the Growth of Canine Hemangiosarcoma, 1 January, 2016

Grant No. 02204: Using Enhanced Imaging to Evaluate Tumor Margins for Canine Mammary Cancer and Soft Tissue Sarcoma, 1 January, 2016

Grant No. 01426: c-Kit Mutationand Localization Status as Response Predictors in Canine Mast Cell Tumors Treated with Toceranib, 15 January 2015

Grant No. 02052: Immunoprofiling Canine ITP for Individualized Therapy, 31 January, 2014

Grant No. 01889-Ga: Developing Markers to Diagnose and Guide Cancer Treatment in Golden Retrievers Based on Newly Discovered Heritable and Acquired Mutations, 31 January, 2014

Grant No. 01994: Mitral Valve Leaflet Strain in Dog Breeds at Risk for Myxomatous Mitral Valve Degeneration, 31 January, 2014

Grant No. 01753: Identification of genetic modifiers that impact clinical expression of arrhythmogenic right ventricular cardiomyopathy in the Boxer dog, 22 January, 2013

Grant No. 01759: Targeting Multipotency to Arrest Hemangiosarcoma Progression and Improve Outcomes, 22 January, 2013

Grant No. 01760: Therapeutic gene transfer abrogates canine dilated cardiomyopathy, 22 January, 2013

Grant No. 01859-A: Evaluation of Occurrence of Ventricular Arrhythmias in Normal Saluki Dogs , 9 July, 2013

Grant No. 01268: Investigation to identify genes associated with canine immune-mediated haemolytic anaemia, 10 January, 2011

Grant No. 01429: Mechanistic Relationship of IL-8 in Cell Proliferation and Survival of Canine Hemangiosarcoma, 10 January, 2011

Grant No. 00908: Serotonin Type 2A Receptor Antagonist Therapy for Preventing the Progression of Myxomatous Mitral Valve Disease, 5 April, 2010

Grant No. 01131: Genetic Background and the Angiogenic Phenotype in Cancer, 6 October, 2009

Grant No. 01355-A: Expression of Vascular Endothelial markers in Canine Hemangiosarcoma and their use in Diagnostic Cytology Using Immunocytochemistry, 6 October, 2009

Grant No. 01147: Identifying Mutations in Genes Associated with Canine Hemangiosarcoma, 18 February, 2009

Grant No. 00947A: Heritable and Sporadic Genetic Lesions in Canine Osteosarcoma, 18 June, 2008

Grant No. 00613: The Prognostic Significance of Chromosome Aneuploidy in Canine Lymphoma, 18 June, 2008

Grant No. 00757A: Hereditary Mutations in Genes Associated with Osteosarcoma in Large Dog Breeds, 18 June, 2008, Report is CONFIDENTIAL

Grant No. 00947B: Heritable and Sporadic Genetic Lesions in Canine Osteosarcoma, 18 June 2008

Grant No. 00593A: Mapping Genes Associated with Canine Hemangiosarcoma, 30 November 2007, Report is CONFIDENTIAL

Grant No. 0002045: Bone Mineral Densitometry in Dogs: Effect of Body Size and Exercise on Bone Size and Bone Density, 30 June, 2003, Report is CONFIDENTIAL

SHR Donor Advised Fund statement 2009

SHR Donor Advised Fund statement 2015